| Code | 5872D | ||||||||||
| MA number | 44/0254/20-S | ||||||||||
| Product Form: | con inf 1x4,5 ml/45 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | EVER Valinject GmbH, Austria | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 26.11.2020 |
| SPC: |
SPC_Cabazitaxel EVER Pharma 10 mg_ml koncentrát na infúzny roztok_08.2023.pdf
|
| PIL: |
PIL_Cabazitaxel EVER Pharma 10 mg_ml koncentrát na infúzny roztok_10.2023.pdf
|
| Safety feature | Yes |
| Data update: | 30.01.2025 |
